CERS logo

CERSCerus Corp.

$2.59
$0.03
(1.17%)
Today
Closed $2.59
$0.00
(0.00%)
After Hours
Updated: 06:36 PM EDT
EarningsAug 4
Mkt Cap$512.94M
Vol3.86M
News
all
press releases
Cerus Corporation Closes New Debt Facility of Up to $110 Million
Cerus Corporation (Nasdaq: CERS) announced today the closing of a new debt facility with MidCap Financial (MidCap), providing up to $110 million. The facility consists of a 5-year term loan and an asset-backed revolving loan. The refinancing is expected to reduce annual cash interest expense by up...
Business Wire
News Placeholder
More News
News Placeholder
Is BrightSpring Health Services, Inc. (BTSG) Stock Outpacing Its Medical Peers This Year?
Here is how BrightSpring Health Services, Inc. (BTSG) and Cerus (CERS) have performed compared to their sector so far this year.
Zacks
News Placeholder
Vivek Jayaraman Sells 16,667 Shares of Cerus (NASDAQ:CERS) Stock
Cerus Corporation (NASDAQ:CERS - Get Free Report) COO Vivek Jayaraman sold 16,667 shares of Cerus stock in a transaction that occurred on Friday, May 1st. The shares were sold at an average price of...
MarketBeat
News Placeholder
Cerus (NASDAQ:CERS) Sees Unusually-High Trading Volume Following Analyst Upgrade
Cerus (NASDAQ:CERS) Sees Strong Trading Volume Following Analyst Upgrade...
MarketBeat
News Placeholder
Top 3 Health Care Stocks That May Collapse This Month
Stocks AVNS, APLS, and CERS in healthcare sector flashing warning to momentum-sensitive investors. High RSI values & price action indicate overbought conditions. AVNS at 90. APLS at 86. CERS at 86...
Benzinga
News Placeholder
Cerus (NASDAQ:CERS) Upgraded by Zacks Research to Hold Rating
Zacks Research raised shares of Cerus from a "strong sell" rating to a "hold" rating in a research note on Thursday...
MarketBeat
News Placeholder
Cerus (NASDAQ:CERS) Upgraded by Wall Street Zen to Buy Rating
Wall Street Zen raised shares of Cerus from a 'hold' rating to a 'buy' rating in a report on Saturday...
MarketBeat
News Placeholder
Cerus (NASDAQ:CERS) Reaches New 12-Month High After Better-Than-Expected Earnings
Cerus (NASDAQ:CERS) Reaches New 12-Month High on Better-Than-Expected Earnings...
MarketBeat
News Placeholder
BTIG Research Upgrades Cerus (NASDAQ:CERS) to "Buy"
BTIG Research upgraded Cerus from a "neutral" rating to a "buy" rating and set a $4.00 price objective for the company in a research note on Friday...
MarketBeat
News Placeholder
Cerus (NASDAQ:CERS) Issues Quarterly Earnings Results, Beats Estimates By $0.02 EPS
Cerus (NASDAQ:CERS - Get Free Report) released its quarterly earnings data on Thursday. The biotechnology company reported ($0.01) earnings per share for the quarter, topping the consensus estimate...
MarketBeat
<
1
2
...
>

Advertisement|Remove ads.